REGENERON PHARMACEUTICALS, INC. (REGN) /
The revenue of REGENERON PHARMACEUTICALS, INC. over the past 10 years
Chart REGENERON PHARMACEUTICALS, INC.: revenue, fiscal 2016–2025 Open the chart →REGENERON PHARMACEUTICALS, INC. reported revenue of $14.34B in fiscal 2025, the latest fiscal year on file. In fiscal 2016 it was $4.86B — up 195% over 9 years. Year over year, revenue rose 7 times and fell twice. In these years the highest was $16.07B in fiscal 2021. The largest one-year move was in fiscal 2021: up 89%, from $8.5B to $16.07B.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $14.34B |
| 2024ended Dec 31, 2024 | $14.2B |
| 2023ended Dec 31, 2023 | $13.12B |
| 2022ended Dec 31, 2022 | $12.17B |
| 2021ended Dec 31, 2021 | $16.07B |
| 2020ended Dec 31, 2020 | $8.5B |
| 2019ended Dec 31, 2019 | $6.56B |
| 2018ended Dec 31, 2018 | $5.15B |
| 2017ended Dec 31, 2017 | $5.87B |
| 2016ended Dec 31, 2016 | $4.86B |
Fiscal years as REGENERON PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on REGENERON PHARMACEUTICALS, INC.
- The profitability of REGENERON PHARMACEUTICALS, INC.
- The cash flow of REGENERON PHARMACEUTICALS, INC.
- The debt of REGENERON PHARMACEUTICALS, INC.
- The dividends of REGENERON PHARMACEUTICALS, INC.
- All of REGENERON PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- UPSUNITED PARCEL SERVICE INC
- TRVTravelers Companies, Inc.
- EOGEOG RESOURCES, INC.
- MCOMoody’s Corporation
- CDNSCADENCE DESIGN SYSTEMS, INC.
Not investment advice. This page shows what REGENERON PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.